Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Velsa rādītājs dziļo vēnu trombozei (DVT)× | CHA₂DS₂-VASc Score× | |
|---|---|---|
| Nozare | Klīniskā novērtēšana | Klīniskā novērtēšana |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1994 | 2010 |
| Autors≠ | Philip S. Wells | Gregory Y. H. Lip, Robby Nieuwlaat, et al. |
| Tips≠ | Venous thromboembolism risk stratification | Atrial fibrillation stroke risk stratification |
| Pirmavots≠ | Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546. link ↗ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ |
| Citi nosaukumi | Wells DVT Score, DVT Wells | CHA2DS2VASc, Atrial fibrillation stroke risk |
| Saistītās | 3 | 3 |
| Kopsavilkums≠ | The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients. | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. |
| ScholarGateDatu kopa ↗ |
|
|